429 related articles for article (PubMed ID: 16845624)
1. Oral herpes simplex virus type 2 reactivation in HIV-positive and -negative men.
Kim HN; Meier A; Huang ML; Kuntz S; Selke S; Celum C; Corey L; Wald A
J Infect Dis; 2006 Aug; 194(4):420-7. PubMed ID: 16845624
[TBL] [Abstract][Full Text] [Related]
2. Herpes simplex virus type 2 shedding in human immunodeficiency virus-negative men who have sex with men: frequency, patterns, and risk factors.
Krone MR; Wald A; Tabet SR; Paradise M; Corey L; Celum CL
Clin Infect Dis; 2000 Feb; 30(2):261-7. PubMed ID: 10671325
[TBL] [Abstract][Full Text] [Related]
3. Genital shedding of herpes simplex virus among men.
Wald A; Zeh J; Selke S; Warren T; Ashley R; Corey L
J Infect Dis; 2002 Oct; 186 Suppl 1():S34-9. PubMed ID: 12353185
[TBL] [Abstract][Full Text] [Related]
4. Reactivation of genital herpes simplex virus type 2 infection in asymptomatic seropositive persons.
Wald A; Zeh J; Selke S; Warren T; Ryncarz AJ; Ashley R; Krieger JN; Corey L
N Engl J Med; 2000 Mar; 342(12):844-50. PubMed ID: 10727588
[TBL] [Abstract][Full Text] [Related]
5. Herpes simplex virus shedding and plasma human immunodeficiency virus RNA levels in coinfected women.
Augenbraun M; Corey L; Reichelderfer P; Wright DJ; Burns D; Koelle DM; Robison E; Cohen M;
Clin Infect Dis; 2001 Sep; 33(6):885-90. PubMed ID: 11512094
[TBL] [Abstract][Full Text] [Related]
6. The effect of daily valacyclovir suppression on herpes simplex virus type 2 viral shedding in HSV-2 seropositive subjects without a history of genital herpes.
Sperling RS; Fife KH; Warren TJ; Dix LP; Brennan CA
Sex Transm Dis; 2008 Mar; 35(3):286-90. PubMed ID: 18157071
[TBL] [Abstract][Full Text] [Related]
7. Valacyclovir and acyclovir for suppression of shedding of herpes simplex virus in the genital tract.
Gupta R; Wald A; Krantz E; Selke S; Warren T; Vargas-Cortes M; Miller G; Corey L
J Infect Dis; 2004 Oct; 190(8):1374-81. PubMed ID: 15378428
[TBL] [Abstract][Full Text] [Related]
8. Topical resiquimod 0.01% gel decreases herpes simplex virus type 2 genital shedding: a randomized, controlled trial.
Mark KE; Corey L; Meng TC; Magaret AS; Huang ML; Selke S; Slade HB; Tyring SK; Warren T; Sacks SL; Leone P; Bergland VA; Wald A
J Infect Dis; 2007 May; 195(9):1324-31. PubMed ID: 17397003
[TBL] [Abstract][Full Text] [Related]
9. One-day regimen of valacyclovir for treatment of recurrent genital herpes simplex virus 2 infection.
Bavaro JB; Drolette L; Koelle DM; Almekinder J; Warren T; Tyring S; Wald A
Sex Transm Dis; 2008 Apr; 35(4):383-6. PubMed ID: 18362859
[TBL] [Abstract][Full Text] [Related]
10. HSV oropharyngeal shedding among HIV-infected children in Tanzania.
Zuckerman R; Manji K; Matee M; Naburi H; Bisimba J; Martinez R; Wieland-Alter W; Kim F; von Reyn CF; Palumbo P
Int J STD AIDS; 2015 Jun; 26(7):456-61. PubMed ID: 25028453
[TBL] [Abstract][Full Text] [Related]
11. Genital tract shedding of herpes simplex virus type 2 in women: effects of hormonal contraception, bacterial vaginosis, and vaginal group B Streptococcus colonization.
Cherpes TL; Melan MA; Kant JA; Cosentino LA; Meyn LA; Hillier SL
Clin Infect Dis; 2005 May; 40(10):1422-8. PubMed ID: 15844064
[TBL] [Abstract][Full Text] [Related]
12. Maternal herpes simplex virus type 2 coinfection increases the risk of perinatal HIV transmission: possibility to further decrease transmission?
Bollen LJ; Whitehead SJ; Mock PA; Leelawiwat W; Asavapiriyanont S; Chalermchockchareonkit A; Vanprapar N; Chotpitayasunondh T; McNicholl JM; Tappero JW; Shaffer N; Chuachoowong R
AIDS; 2008 Jun; 22(10):1169-76. PubMed ID: 18525263
[TBL] [Abstract][Full Text] [Related]
13. Herpes simplex virus (HSV) suppression with valacyclovir reduces rectal and blood plasma HIV-1 levels in HIV-1/HSV-2-seropositive men: a randomized, double-blind, placebo-controlled crossover trial.
Zuckerman RA; Lucchetti A; Whittington WL; Sanchez J; Coombs RW; Zuñiga R; Magaret AS; Wald A; Corey L; Celum C
J Infect Dis; 2007 Nov; 196(10):1500-8. PubMed ID: 18008230
[TBL] [Abstract][Full Text] [Related]
14. Changes in plasma human immunodeficiency virus type 1 RNA associated with herpes simplex virus reactivation and suppression.
Schacker T; Zeh J; Hu H; Shaughnessy M; Corey L
J Infect Dis; 2002 Dec; 186(12):1718-25. PubMed ID: 12447756
[TBL] [Abstract][Full Text] [Related]
15. Determinants of HIV type 1 shedding from genital ulcers among men in South Africa.
Paz-Bailey G; Sternberg M; Puren AJ; Steele L; Lewis DA
Clin Infect Dis; 2010 Apr; 50(7):1060-7. PubMed ID: 20178417
[TBL] [Abstract][Full Text] [Related]
16. High incidence of genotypic variance between sequential herpes simplex virus type 2 isolates from HIV-1-seropositive patients with recurrent genital herpes.
Roest RW; Maertzdorf J; Kant M; van der Meijden WI; Osterhaus AD; Verjans GM
J Infect Dis; 2006 Oct; 194(8):1115-8. PubMed ID: 16991086
[TBL] [Abstract][Full Text] [Related]
17. Virologic characteristics of subclinical and symptomatic genital herpes infections.
Wald A; Zeh J; Selke S; Ashley RL; Corey L
N Engl J Med; 1995 Sep; 333(12):770-5. PubMed ID: 7643884
[TBL] [Abstract][Full Text] [Related]
18. Frequent reactivation of herpes simplex virus among HIV-1-infected patients treated with highly active antiretroviral therapy.
Posavad CM; Wald A; Kuntz S; Huang ML; Selke S; Krantz E; Corey L
J Infect Dis; 2004 Aug; 190(4):693-6. PubMed ID: 15272395
[TBL] [Abstract][Full Text] [Related]
19. Vitamin A supplementation and genital shedding of herpes simplex virus among HIV-1-infected women: a randomized clinical trial.
Baeten JM; McClelland RS; Corey L; Overbaugh J; Lavreys L; Richardson BA; Wald A; Mandaliya K; Bwayo JJ; Kreiss JK
J Infect Dis; 2004 Apr; 189(8):1466-71. PubMed ID: 15073684
[TBL] [Abstract][Full Text] [Related]
20. Herpes simplex virus type 2 and risk of intrapartum human immunodeficiency virus transmission.
Drake AL; John-Stewart GC; Wald A; Mbori-Ngacha DA; Bosire R; Wamalwa DC; Lohman-Payne BL; Ashley-Morrow R; Corey L; Farquhar C
Obstet Gynecol; 2007 Feb; 109(2 Pt 1):403-9. PubMed ID: 17267842
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
